Pennant Group Past Earnings Performance
Past criteria checks 5/6
Pennant Group has been growing earnings at an average annual rate of 2.2%, while the Healthcare industry saw earnings declining at 1.2% annually. Revenues have been growing at an average rate of 11.8% per year. Pennant Group's return on equity is 10.3%, and it has net margins of 2.9%.
Key information
2.2%
Earnings growth rate
9.3%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 11.8% |
Return on equity | 10.3% |
Net Margin | 2.9% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pennant Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 575 | 16 | 88 | 0 |
31 Dec 23 | 545 | 13 | 84 | 0 |
30 Sep 23 | 524 | 13 | 81 | 0 |
30 Jun 23 | 502 | 13 | 77 | 0 |
31 Mar 23 | 486 | 7 | 77 | 0 |
31 Dec 22 | 473 | 7 | 78 | 0 |
30 Sep 22 | 460 | 1 | 80 | 0 |
30 Jun 22 | 454 | -3 | 83 | 0 |
31 Mar 22 | 448 | 3 | 83 | 0 |
31 Dec 21 | 440 | 3 | 81 | 0 |
30 Sep 21 | 436 | 9 | 81 | 0 |
30 Jun 21 | 422 | 12 | 81 | 0 |
31 Mar 21 | 405 | 14 | 77 | 0 |
31 Dec 20 | 391 | 16 | 75 | 0 |
30 Sep 20 | 372 | 8 | 71 | 0 |
30 Jun 20 | 362 | 5 | 64 | 0 |
31 Mar 20 | 352 | 4 | 64 | 0 |
31 Dec 19 | 339 | 3 | 61 | 0 |
30 Sep 19 | 324 | 10 | 57 | 0 |
30 Jun 19 | 309 | 13 | 55 | 0 |
31 Mar 19 | 296 | 14 | 51 | 0 |
31 Dec 18 | 286 | 16 | 49 | 0 |
31 Dec 17 | 251 | 10 | 46 | 0 |
31 Dec 16 | 217 | 8 | 41 | 0 |
Quality Earnings: 1ZU has high quality earnings.
Growing Profit Margin: 1ZU's current net profit margins (2.9%) are higher than last year (1.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1ZU's earnings have grown by 2.2% per year over the past 5 years.
Accelerating Growth: 1ZU's earnings growth over the past year (119.7%) exceeds its 5-year average (2.2% per year).
Earnings vs Industry: 1ZU earnings growth over the past year (119.7%) exceeded the Healthcare industry 9.9%.
Return on Equity
High ROE: 1ZU's Return on Equity (10.3%) is considered low.